
Investors
Long-term value creation in our core spaces for our stakeholders with a distinct purpose of ensuring that every family will have a better tomorrow


Financial Snapshot
75
Years in Operation
USD
159 mn
Market Capitalisation37%
Free Float
USD
311 mn
Total AssetsAAA
Long-term Fitch Rating>5K
EmployeesLatest News
Performance Review for the Twelve Months Ended 31 st March 2025
May 22, 2025
Hemas Appoints Dr. Mahesha Ranasoma as Managing Director of Hemas Pharmaceuticals and Hemas Surgicals & Diagnostics to Strengthen Healthcare Partnerships
April 07, 2025
Hemas Hospital Wattala enters Cardiac Care, with Sri Lanka’s Most Advanced Technology in cardiac catheterization
April 04, 2025